Drug
Menotrophin
Menotrophin is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_4
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
2(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completed
A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility
NCT02835469
completed
A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®
NCT02935335
completedphase_4
Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
NCT01225835
completedphase_4
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa
NCT00257556
Clinical Trials (4)
Showing 4 of 4 trials
NCT02835469
A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility
NCT02935335
A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®
NCT01225835Phase 4
Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
NCT00257556Phase 4
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4